Does ROZANOLIXIZUMAB-NOLI Cause Off label use? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Off label use have been filed in association with ROZANOLIXIZUMAB-NOLI. This represents 4.0% of all adverse event reports for ROZANOLIXIZUMAB-NOLI.
14
Reports of Off label use with ROZANOLIXIZUMAB-NOLI
4.0%
of all ROZANOLIXIZUMAB-NOLI reports
0
Deaths
5
Hospitalizations
How Dangerous Is Off label use From ROZANOLIXIZUMAB-NOLI?
Of the 14 reports, 5 (35.7%) required hospitalization.
Is Off label use Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for ROZANOLIXIZUMAB-NOLI. However, 14 reports have been filed with the FAERS database.
What Other Side Effects Does ROZANOLIXIZUMAB-NOLI Cause?
Myasthenia gravis (57)
Drug ineffective (51)
Headache (48)
Nausea (29)
Diarrhoea (27)
Fatigue (27)
Dyspnoea (19)
Hospitalisation (19)
Vomiting (17)
Therapy interrupted (15)
What Other Drugs Cause Off label use?
RITUXIMAB (39,751)
INFLIXIMAB (34,801)
DENOSUMAB (34,612)
METHOTREXATE (24,020)
VEDOLIZUMAB (21,017)
ETANERCEPT (20,178)
TOCILIZUMAB (18,256)
PREDNISONE (17,867)
LENALIDOMIDE (17,017)
ADALIMUMAB (16,417)
Which ROZANOLIXIZUMAB-NOLI Alternatives Have Lower Off label use Risk?
ROZANOLIXIZUMAB-NOLI vs RUBIDIUM RB-82
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB
ROZANOLIXIZUMAB-NOLI vs RUCAPARIB CAMSYLATE
ROZANOLIXIZUMAB-NOLI vs RUFINAMIDE
ROZANOLIXIZUMAB-NOLI vs RUPATADINE